Cite

HARVARD Citation

    Konstantinopoulos, P. et al. (2023). A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor–Positive Recurrent Endometrial Cancer. Journal of clinical oncology. 41 (3), pp. 599-608. [Online]. 
  
Back to record